A clinical evaluation of the Dideco Kids D100 neonatal oxygenatora

Abstract

In August 2006, Duke University Perfusion Services had the opportunity to be the first institution in the United States to clinically evaluate the Dideco D100 Neonatal Oxygenator. The device was used on six pediatric patients to facilitate correction or palliation of their cardiac defects, which included two arterial switch operations, two truncus arteriosus repairs, one stage 1 Norwood and one repair of total anomalous pulmonary venous return. The average patient weight was 3.1 kg. The average cardiopulmonary bypass(CPB) time was 135 minutes and the average cross-clamp time was 61 minutes. Arterial and venous blood gasses were drawn and used to calculate oxygen transfer. The average oxygen transfer was 14.8 ± 10.3 ml/O₂/min. The Dideco D100 Oxygenator is the first oxygenation device designed specifically for neonates. The Dideco D100 is a microporous hollow-fiber device. It has a static priming volume of 31 ml and a maximum rated flow of 700 ml/min. The integral hard-shell venous reservoir has a minimum operating level of 10 ml and a reservoir capacity of 500 ml. For this evaluation, the Dideco Kids D100 Neonatal Oxygenator performed adequately on patients weighing up to 5 kg. This device provides an excellent first step towards offering very small children appropriate circuitry without having to sacrifice safety or performance.

Keywords

oxygenator oxygen transfer neonatal Cardiopulmonary Bypass (CPB)

Get full access to this article

View all access options for this article.

References

1 McElhinney DB Wernovsky G . Outcomes of neonates with congenital heart disease. Curr Opin Pediatr 2001; 13: 104–110.

2 Majnemer A Limperopoulos C . Developmental progress of children with congenital heart defects requiring open heart surgery. Semin Pediatr Neurol 1999; 6: 12–19.

3 Mahle WT Wernovsky G . Long-term developmental outcome of children with complex congenital heart disease. Clinics in Perinatology 2001; 28: 235–247.

4 Limperopoulos C Majnemer A Shevell MI . Predictors of developmental disabilities after open heart surgery in young children with congenital heart disease. J Pediatr 2002; 141: 51–58.

5 Bellinger DC Wypij D Kuban KC . Developmental and neurological status of children at 4 years of age after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. Circulation 1999; 100: 526–532.

6 Goldberg CS Schwartz EM Brunberg JA . Neurodevelopmental outcome of patients after the Fontan operation: a comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J Pediatr 2000; 137: 646–652.

7 Forbess JM Visconti KJ Hancock-Friesen C . Neurodevelopmental outcome after congenital heart surgery: results from an institutional registry. Circulation 2002; 106: I95–I102.

8 DuPlessis AJ . Mechanisms of brain injury during infant cardiac surgery. Semin Pediatr Neurol 1999; 6: 32–47.

9 Jaggers JJ Ungerleider RM . Cardiopulmonary bypass in infants and children. In: C Mavroudis CL Backer , eds. Pediatric cardiac surgery. Mosby, Philadelphia 2003:171-193.

10.

10 Duebener LF Sakamoto T Hatsuoka S . Effects of hematocrit on cerebral microcirculation and tissue oxygenation during deep hypothermic bypass. Circulation 2001; 104: I260–I264.

11.

11 Shin’oka T Shum-Tim D Laussen PC . Effects of oncotic pressure and hematocrit on outcome after hypothermic circulatory arrest. Ann Thorac Surg 1998; 65: 155–164.

12.

12 Jonas RA Wypij D Roth SJ . The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass results of a randomized trial in infants. J Thorac Cardiovasc Surg 2003; 126: 1765–1774.

13.

13 Gruber EM Jonas RA Newburger JW . The effect of hematocrit on cerebral blood flow velocity in neonates and infants undergoing deep hypothermic CPB. Anesth Analg 1999; 89: 322–327.

14.

14 Wan S LeClerc JL Vincent JL . Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676–692.

15.

15 Lodge AJ Chai PJ Daggett CW Ungerleider RM Jaggers J . Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Surg 1999; 117: 515–522.

16.

16 Molicki JS Draaisma AM Verbeet N . Prime solutions for cardiopulmonary bypass in neonates: antioxidant capacity of prime based on albumin or fresh frozen plasma. J Thorac Cardiovasc Surg 2001; 122: 449–456.

17.

17 Lau CL Posther KE Stephenson GR . Minicircuit cardiopulmonary bypass with vacuum-assisted venous drainage: feasibility of an asanguineous prime in the neonate. Perfusion 1999; 14: 389–396.

18.

18 Kern F Schulman SR Lawson DS Darling EM . Extracorporeal circulation and circulatory assist devices in the pediatric patient. In: CL Lake , ed. Pediatric Cardiac Anesthesia, third edition. Stamford, CT: Appleton and Lange, 1998: 219-257.

19.

19 Darling E Kaemmer D Lawson S . Experimental use of an ultra-low prime neonatal cardiopulmonary bypass circuit utilizing vacuum-assisted venous drainage. J Extracorpor Tech 1998; 30: 184–189.